Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Temocillin

Generic Name: Temocillin

Drug Type: Small Molecule

Chemical Formula: C_₁₆H_₁₈N_₂O_₇S_₂

CAS Number: 66148-78-5

Unique Ingredient Identifier: 03QB156W6I

Overview

Temocillin has been investigated in Infection, Liver Dysfunction, and Urinary Tract Infection.

Background

Temocillin has been investigated in Infection, Liver Dysfunction, and Urinary Tract Infection.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Piperacillin-tazobactam and Temocillin as Carbapenem-alternatives for the Treatment of Severe Infections Due to Extended-spectrum Beta-lactamase-Producing Gram-negative Enterobacteriaceae in the Intensive Care Unit

Phase 3

Recruiting

Posted: 2022/10/04

Sponsor:Assistance Publique ...

ID:NCT05565222

Temocillin vs Meropenem for the Targeted Treatment of Bacteraemia Resistant to Third Gen Cephalosporins

Phase 3

Recruiting

Posted: 2020/07/21

Sponsor:Fundación Pública An...

ID:NCT04478721

Plasma Protein Binding and PK/PD of Total and Unbound Temocillin Non-ICU Patients

Not Applicable

Posted: 2018/06/15

Sponsor:

Paul M. Tulkens

ID:NCT03557840

Temocillin Versus a Carbapenem as Initial Intravenous Treatment for ESBL Related Urinary Tract Infections

Phase 3

Completed

Posted: 2018/06/01

Sponsor:Assistance Publique ...

ID:NCT03543436

Disturbance of the Intestinal Microbiota by Temocillin vs Cefotaxime in Treatment of Febrile Urinary Tract Infections

Phase 4

Completed

Posted: 2016/11/09

Sponsor:

Håkan Hanberger

ID:NCT02959957

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy